Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,572 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial.
Kodera Y, Takahashi N, Yoshikawa T, Takiguchi N, Fujitani K, Ito Y, Miyamoto K, Takayama O, Imano M, Kobayashi D, Miyashita Y, Morita S, Sakamoto J. Kodera Y, et al. Among authors: miyamoto k. Gastric Cancer. 2017 Jan;20(1):190-199. doi: 10.1007/s10120-016-0598-0. Epub 2016 Feb 15. Gastric Cancer. 2017. PMID: 26879545 Clinical Trial.
[Trial of home infusion therapy for near-terminal stage patients with lung cancer].
Kozaki Y, Miyamoto K, Sumioka N, Wada T, Kanamori Y, Murakami T, Doi Y, Yoneda M, Hada Y, Hirashima T, Ogawa T, Ikeda Y, Hamaguchi T, Hayashi E, Oda T, Kimura K, Kawase I. Kozaki Y, et al. Among authors: miyamoto k. Gan To Kagaku Ryoho. 1996 Dec;23 Suppl 3:305-10. Gan To Kagaku Ryoho. 1996. PMID: 8982320 Japanese.
A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial.
Takahashi N, Kanda M, Yoshikawa T, Takiguchi N, Fujitani K, Miyamoto K, Ito Y, Takayama O, Imano M, Mitsumori N, Sakamoto J, Morita S, Kodera Y. Takahashi N, et al. Among authors: miyamoto k. Gastric Cancer. 2018 Nov;21(6):1014-1023. doi: 10.1007/s10120-018-0817-y. Epub 2018 Mar 13. Gastric Cancer. 2018. PMID: 29536296 Clinical Trial.
Rice transcription factor bHLH25 confers resistance to multiple diseases by sensing H2O2.
Liao H, Fang Y, Yin J, He M, Wei Y, Zhang J, Yong S, Cha J, Song L, Zhu X, Chen X, Kováč J, Hou Q, Ma Z, Zhou X, Chen L, Yumoto E, Yang T, He Q, Li W, Deng Y, Li H, Li M, Qing H, Zou L, Bi Y, Liu J, Yang Y, Ye D, Tao Q, Wang L, Xiong Q, Lu X, Tang Y, Li T, Ma B, Qin P, Li Y, Wang W, Qian Y, Ďurkovič J, Miyamoto K, Chern M, Li S, Li W, Wang J, Chen X. Liao H, et al. Among authors: miyamoto k. Cell Res. 2025 Jan 14. doi: 10.1038/s41422-024-01058-4. Online ahead of print. Cell Res. 2025. PMID: 39806170
3,572 results